Skip to main content

Table 1 Comparison between group I (control group) and group II (case group) regarding cure rate after treatment

From: Effectiveness and safety of ombitasvir/paritaprevir/ritonavir in treatment of chronic hepatitis C Egyptian hemodialysis patients, case-control study

Cure

Group I

Group II

Test value*

p value

No. = 50

No. = 41

Complete

50 (100.0%)

39 (95.1%)

2.494

0.114

Relapse

0 (0.0%)

2 (4.9%)

  1. *Chi-square test